The safety and ablation efficacy of ultrasound-guided high-intensity focused ultrasound ablation for desmoid tumors

References

• Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. editors. WHO classification of tumours of soft tissue and bone. Pathology and genetics of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.
   Google Scholar
• van Broekhoven DL, Grunhagen DJ, den Bakker MA, et al. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study. Ann Surg Oncol. 2015;22(9):2817–2823.
   PubMed Web of Science ®Google Scholar
• Kasper B, Baumgarten C, Garcia J, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017;28(10):2399–2408.
   PubMed Web of Science ®Google Scholar
• Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist. 2011;16(5):682–693.
   PubMed Web of Science ®Google Scholar
• Clark SK, Neale KF, Landgrebe JC, et al. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg. 1999;86(9):1185–1189.
   PubMed Web of Science ®Google Scholar
• Sinha A, Tekkis PP, Gibbons DC, et al. Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis. Colorectal Dis. 2011;13(11):1222–1229.
   PubMed Web of Science ®Google Scholar
• Koskenvuo L, Ristimäki A, Lepistö A. Comparison of sporadic and FAP-associated desmoid-type fibromatoses. J Surg Oncol. 2017;116(6):716–721.
   PubMed Web of Science ®Google Scholar
• Crago AM, Denton B, Salas S, et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 2013;258(2):347–353.
   PubMed Web of Science ®Google Scholar
• Shin SH, Ko KR, Cho SK, et al. Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes. J Surg Oncol. 2013;108(1):28–33.
   PubMed Web of Science ®Google Scholar
• Bishop AJ, Zarzour MA, Ratan R, et al. Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: a 10-year update and re-evaluation of the role of radiation therapy for younger patients. Int J Radiat Oncol Biol Phys. 2019;103(5):1167–1174.
   PubMed Web of Science ®Google Scholar
• Guadagnolo BA, Zagars GK, Ballo MT. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008;71(2):441–447.
   PubMed Web of Science ®Google Scholar
• von Mehren M, Randall RL, Benjamin RS, et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(5):536–563.
   PubMed Web of Science ®Google Scholar
• Park JS, Nakache YP, Katz J, et al. Conservative management of desmoid tumors is safe and effective. J Surg Res. 2016;205(1):115–120.
   PubMed Web of Science ®Google Scholar
• Desmoid TW. G. The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer. 2020;127:96–107.
   PubMed Web of Science ®Google Scholar
• Azzarelli MDA, Gronchi MDA, Bertulli MDR, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer. 2001;92(5):1259–1264.
   PubMed Web of Science ®Google Scholar
• Li S, Fan Z, Fang Z, et al. Efficacy of vinorelbine combined with low-dose methotrexate for treatment of inoperable desmoid tumor and prognostic factor analysis. Chin J Cancer Res. 2017;29(5):455–462.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Hamada S, Sakai T, et al. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review. Jpn J Clin Oncol. 2020;50(4):419–424.
   PubMed Web of Science ®Google Scholar
• Chugh R, Wathen JK, Patel SR, et al. Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res. 2010;16(19):4884–4891.
   PubMed Web of Science ®Google Scholar
• Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med. 2018;379(25):2417–2428.
   PubMed Web of Science ®Google Scholar
• Ng KK, Poon RT, Chan SC, et al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg. 2011;253(5):981–987.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, et al. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 2004;30(2):245–260.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhu H, Zhang L, et al. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation. Radiology. 2010;255(3):967–978.
   PubMed Web of Science ®Google Scholar
• Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;27(11):1422–1428.
   Web of Science ®Google Scholar
• Vidal-Jove J, Perich E, Del Castillo MA. Ultrasound guided high intensity focused ultrasound for malignant tumors: the Spanish experience of survival advantage in stage III and IV pancreatic cancer. Ultrason Sonochem. 2015;27:703–706.
   PubMed Web of Science ®Google Scholar
• Orsi F, Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol. 2010;195(3):W245–W252.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang W, Tang J. Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: preliminary results. Int J Hyperthermia. 2011;27(7):648–653.
   PubMed Web of Science ®Google Scholar
• Ghanouni P, Dobrotwir A, Bazzocchi A, et al. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. Eur Radiol. 2017;27(2):732–740.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Han ZY, Zhang J, et al. Early experience: high-intensity focused ultrasound treatment for intra-abdominal aggressive fibromatosis of failure in surgery. Br J Radiol. 2016;89(1062):20151026.
   PubMed Web of Science ®Google Scholar
• Shi Y, Huang Y, Zhou M, et al. High-intensity focused ultrasound treatment for intra-abdominal desmoid tumors: a report of four cases. J Med Ultrason (2001). 2016;43(2):279–284.
   PubMed Web of Science ®Google Scholar
• Najafi A, Fuchs B, Binkert CA. Mid-term results of MR-guided high-intensity focused ultrasound treatment for relapsing superficial desmoids. Int J Hyperthermia. 2019;36(1):538–542.
   PubMed Web of Science ®Google Scholar
• Griffin MO, Kulkarni NM, OʼConnor SD, et al. Magnetic resonance-guided focused ultrasound: a brief review with emphasis on the treatment of extra-abdominal desmoid tumors. Ultrasound Q. 2019;35(4):346–354.
   PubMed Web of Science ®Google Scholar
• Avedian RS, Bitton R, Gold G, et al. Is MR-guided high-intensity focused ultrasound a feasible treatment modality for desmoid tumors? Clin Orthop Relat Res. 2016;474(3):697–704.
   PubMed Web of Science ®Google Scholar
• Peng S, Zhang L, Hu L, et al. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study. Medicine (Baltimore). 2015;94(13):e650.
   PubMed Web of Science ®Google Scholar
• Peng S, Hu L, Chen W, et al. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids. Ultrasonics. 2015;58:123–128.
   PubMed Web of Science ®Google Scholar
• Common Terminology Criteria for Adverse Events (CTCAE) v5.0. U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute; 2017 [cited 2017 Nov 27]. Available from: https://www.meddra.org/
   Google Scholar
• Cun JP, Fan HJ, Zhao W, et al. Factors influencing MR changes associated with sacral injury after high-intensity focused ultrasound ablation of uterine fibroids. Int J Hyperthermia. 2019;36(1):21–28.
   PubMed Web of Science ®Google Scholar
• Gronchi A, Jones RL. Treatment of desmoid tumors in 2019. JAMA Oncol. 2019;5(4):567–568.
   PubMed Web of Science ®Google Scholar